BioCryst Pharmaceuticals Articles

BioCryst Pharma restructures in face of pipeline disappointments

10 December 2012

M&A briefs: BioCryst/Presidio; Pfizer/Nestle; Teva

3 December 2012

BioCryst withdraws BCX5191 lND following discussion with FDA

4 November 2012

BioCryst and Presidio to merge, creating new competitor in HCV arena

22 October 2012

BioCryst partner Green Cross gets Korean OK to make and market peramivir flu vaccine

17 August 2010

Showing 1-5 of 5 articles

Go to beginningPrevious
  • 1
NextGo to end